Press Releases
 
Fungal Infections - Pipeline Analysis 2018

United States, 14 February 2018 -- Fungal Infection is a major cause of morbidity worldwide. Fungal Infections are caused by different fungi found in environment. Although, some fungi are not dangerous at all but few types of fungi are harmful to health. It involves the invasion of tissue such as skin and lung by specific type of fungi.

According to Centers for Disease Control and Prevention (CDC), a public health institute in the U.S., approximately 1.5 million different species of fungi are present on earth. Out of them, 300 fungi species cause fungal infection in humans. Fungal Infection Trust, a U.K. based organization for the improvement of quality of life of fungal infected patient observed that approximately billion people are affected by fungal infection every year. It is most common among people who are using antineoplastic agents, immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices. Patients with HIV infection, burns, neutropenia and pancreatitis are at high risk of developing fungal infection.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/fungal-infections-pipeline-analysis/report-sample

The fungal infection pipeline has more than 60 drugs. In pipeline analysis, drugs are analyzed based on route of administration and molecule type. The pipeline is also analyzed on the basis of monotherapy and combination therapy, and different clinical phases including Phase III, Phase II, Phase I and Pre-clinical stage.

VB 2862 is a pre-clinical drug candidate of Vyom Biosciences for the treatment of recalcitrant tinea infections. The company is using molecular replacement therapy platform for the development of VB 2862. Preclinical study is also known as animal study. It is done before testing a drug in people to find out the toxicity profile of the drug. Preclinical study is of two types, including in vitro and in vivo.

Browse Other Related report at: https://www.psmarketresearch.com/industry-report/pharmaceuticals

Pipeline analysis provides description about the key companies developing fungal infections drugs. Some of the key players actively involved in the research and development are Moberg Pharma AB, Viamet Pharmaceuticals, Inc., Pulmocide Ltd., Vyom Biosciences, NovaDigm Therapeutics Inc., Matinas BioPharma Holdings Inc., Sol-Gel Technologies Ltd. and Eisai Co. Ltd.

# # #


Submitted by Jacob, P&S Market Research on Wednesday, 14 February 2018 at 8:35 PM
Category: Health Care & Medical
 
Related News

Polymerase Chain Reaction Market: Emergence of Digital PCR Systems to Boost the Growth
Monday, 22 Oct 2018

Radiopharmaceuticals Market to Expand at a CAGR of 5.4% over 2017-2024
Monday, 22 Oct 2018

Oral Thin Film Drugs Market Size, Application Analysis, Regional Outlook, 2017 - 2025
Monday, 22 Oct 2018

Compression Therapy Market: Increasing Popularity of Sports and Other Activities Boosting Market
Monday, 22 Oct 2018

Large Molecule Injectable Drugs Market Size, Application Analysis, Regional Outlook, 2018 - 2026
Monday, 22 Oct 2018

Related Events

National Family Medicine Board Review
Sunday, 21 Oct 2018

92nd Annual Clinical Reviews 2018
Monday, 22 Oct 2018

2nd Annual NASH Summit Europe
Monday, 22 Oct 2018

Precision CRISPR: Drug Discovery and Gene Therapy London 2018
Monday, 22 Oct 2018

Gene Therapy for Rare Disorders Europe Summit
Monday, 22 Oct 2018

Latest News

Future Electronics Participates in McGill University’s Career Fair in Montreal
Tuesday, 23 Oct 2018

Polymerase Chain Reaction Market: Emergence of Digital PCR Systems to Boost the Growth
Monday, 22 Oct 2018

Radiopharmaceuticals Market to Expand at a CAGR of 5.4% over 2017-2024
Monday, 22 Oct 2018

Oral Thin Film Drugs Market Size, Application Analysis, Regional Outlook, 2017 - 2025
Monday, 22 Oct 2018

The Importance Of A great Hair Salon
Monday, 22 Oct 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 23 October 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • National Family Medicine Board Review
  • CRU Ryan's Notes Ferroalloys Conference 2018, Orlando, Florida, USA
  • American Manufacturing Strategies Summit 2018, San Diego
  • American Supply Chain Management Strategies Summit 2018, San Diego
  • 2nd Annual NASH Summit Europe

  • Latest Jobs
    Sorry, there are currently no entries posted here.